Revenue, last quarter
$352.7M
+10.9% vs same quarter last year
Net income
−$32.7M
+42.6% vs same quarter last year
EPS, diluted
−$0.12
+52% vs same quarter last year
Operating cash flow
$21.1M
−55.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.3B | −$231.1M |
| FY24 | $1.3B | −$215.4M |
| FY23 | $1.3B | −$281.2M |
| FY22 | $1.3B | −$370.1M |
| FY21 | $1.2B | −$205.9M |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 49.8% | 2% | −18.2% |
| FY24 | 48% | 1.9% | −16.1% |
| FY23 | 45.6% | 3.2% | −20.9% |
| FY22 | 49.1% | 5.1% | −29% |
| FY21 | 47.6% | 4.9% | −17.2% |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $74.3M |
| FY24 | $71.2M |
| FY23 | $9.8M |
| FY22 | −$88.2M |
| FY21 | −$230.2M |
| FY20 | - |
- Curaleaf
- Healthcare median
Show the numbers
| Year | Curaleaf | Healthcare median |
|---|---|---|
| FY25 | −18.2% | −30.6% |
| FY24 | −16.1% | −47% |
| FY23 | −20.9% | −58% |
| FY22 | −29% | −80.4% |
| FY21 | −17.2% | −71.9% |
| FY20 | - | −62.2% |